FDA Postpones Panel Meeting For VertiFlex’s Superion Spine Device

The FDA postponed a meeting of 1 of its advisory panels that’s slated to review the pre-market approval application for the Superion spine implant made by VertiFlex.

The FDA’s orthopedic & rehabilitation devices panel was originally scheduled to convene Dec. 12, but the federal watchdog agency yesterday said will delay the hearing until Feb. 20, 2015. No reason was given for the postponement.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC